Imagine a unique governance structure that safeguards its mission against the volatile tides of the market. In this episode, Dan Liljenquist, the board chair of Civica Rx, joins Kedar and Don to shed light on Civica's remarkable mission of making essential generic medications both accessible and affordable to patients across the nation. Dan shares how Civica Rx has already had a profound impact, with over 125 million units of essential medicines supplied to over 1500 U.S. hospitals, and is changing the game in terms of pricing, shortages, and market stability. He explains the ethics behind Civica Rx, the non-profit model ensuring the organization's governance and its steadfast commitment to transparency in pricing, aiming at a fair, sustainable market price for all. Dan also discusses the potential expansion of this model into other areas of healthcare, the challenges posed by monopolies in the drug supply, and how Civica Rx is using its leverage to address systemic issues and stabilize a market fraught with abuse and failure. Tune in to this episode for a deep dive into Civica’s revolutionary model aiming to ensure drug availability and pricing stability. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related